The National CFAR CAB Coalition (N3C) brings together expertise to speak on this urgent public health crisis.
Tuesday, August 30, 2022
4-5PM PT | 7-8PM ET
Recording here: https://fb.watch/fn9GGR9QhY/
The National CFAR CAB Coalition (N3C) represents the Centers for AIDS Research (CFAR) Community Action/Advisory Boards (CABs) as a national group of key stakeholders in HIV research and provides a resource for community engagement and involvement in national CFAR initiatives. The N3C serves as a resource for the creation, development, and sustainability of CFAR CABs
This townhall, the first in a series hosted by the N3C, will include presentations, with community discussion and Q&A covering these topics:
* Facts, Misinformation, and Debunking Myths
* Community Perspectives and Messaging
* Remembering HIV and COVID-19 in response to Monkeypox
* Vaccines and Vaccine Rollouts
* Treatment Updates and Access
Cameron R. Wolfe, MBBS, MPH
George S Kerr III
N3C Faith & Spirituality Committee
DC CFAR Community Partner Council
Monica Gandhi, MD, MPH
UCSF-Bay Area CFAR
Timothy Wilkin, MD
Weill Cornell Medicine
Cameron R. Wolfe, MBBS, MPH, FIDSA, FAST, is an Infectious Disease physician, and Associate Professor of Medicine at Duke. His clinical work concentrates on transplant infectious disease, HIV care and managing emerging infectious disease outbreaks for hospitals. Most of his research has been centered around transplant safety, especially for patients and donors who carry hepatitis and HIV. Dr. Wolfe also looks at management and vaccine prevention o emerging biothreat infections, like COVID, monkeypox and other respiratory viral infections in the immunosuppressed.
George Kerr III is a nationally renowned community activist and former grassroots nonprofit executive. For more than 29 years, he continues to be seen as a leader in the fight for social justice in the Greater Washington DC Metropolitan Area. He has been thriving with HIV for over 26 years.
Monica Gandhi MD, MPH is an Infectious Diseases doctor, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF-Bay Area Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic ("Ward 86") at San Francisco General Hospital. Her research focuses on HIV and women and adherence measurement in HIV treatment and prevention and most recently, on how to mitigate the COVID-19 pandemic.
Timothy Wilkin, MD MPH is an infectious diseases doctor, Professor of Medicine and Assistant Dean for Clinical Research Compliance for Human Research Protections at Weill Cornell Medicine. Dr. Wilkin is a prolific clinical trials researcher with a focus on prevention of HPV related cancer in people living with HIV. He is the chair of ACTG A5418, a randomized placebo-controlled trial of tecovirimat for the treatment of human monkeypox virus (HMPXV) disease.